Skip to main content
Advertisement

Weight-Loss Jabs Shift UK Shopping and Eating Habits, Study Finds

Weight-loss jabs like Wegovy and Mounjaro are reshaping UK grocery and dining habits, reducing spending on some foods while increasing others, with cost remaining a key concern for users.

·4 min read
An illustration of a pink credit card, next to an unfurling green measuring tape, against a grid-style backdrop with a green bar chart.

Weight-Loss Jabs Influence UK Shopping Patterns

Weight-loss medications have seen a significant rise in use over recent years, with over two million people in the UK currently using them. Drugs such as Wegovy and Mounjaro have aided many in reducing their weight, but they are also influencing the spending habits of users.

Mounjaro and Wegovy, the UK's most commonly used weight-loss medications, operate by mimicking the natural hormone GLP-1, which regulates hunger. Users report a decreased appetite as a result.

In June, market research firm Worldpanel by Numerator released a study examining how these medications impact grocery spending among UK users. The research utilized survey responses and purchase data from over 11,000 households collected in February.

A major finding was that households with at least one GLP-1 medication user spent an average of £418 less on groceries in the year following the start of their medication compared to households without users.

A graphic showing how weight-loss jab users are spending less on groceries. The data compares GLP-1 user households with non-users in Great Britain, in the year after GLP-1 adoption. There are two bits of receipt paper being held by hands emerging from either side of the graphic. The receipt on the left has -£418 written in pink bold text, which is the average annual saving on grocery bills for per household. The receipt on the right has -£780m written in pink bold text, which is the total saving across all households.

This reduction translates to an estimated £780 million decrease in grocery spending nationwide.

The findings align with a peer-reviewed study from Cornell University published externally last year, which observed that US households with at least one member using weight-loss drugs spent 5% less on groceries within six months of starting the medication. Among higher-income families, this reduction rose to 8%.

Changes in Product Purchases Among Users

Worldpanel's research also revealed that users altered their purchasing habits, reducing some items while increasing others.

As illustrated in the accompanying chart, the control group reported buying less chocolate and pastries and more fruit and protein-rich foods such as prawns. This likely results from feeling fuller for longer and reduced tendencies to eat out of boredom. Additionally, alcohol consumption decreased.

Conversely, purchases of chewing gum, mouthwash, and hair dyes increased — products that address common GLP-1 side effects like thinning hair and bad breath.

A graphic showing how weight-loss jabs are transforming shopping baskets. The data compares GLP-1 user households with non-users in Great Britain, in the year after GLP-1 adoption. Selected products that have seen an increase and decrease in buying among users compared with non-users are shown. Fresh juice/smoothies, prawns, peaches, mouthwash, chewing gum, and hair styling products and dyes have all increased, while fresh bakery, chocolate and alcohol have all decreased. The increases are show as green icons in a shopping trolley being pushed upwards, while the decreases are shown as pink icons below an empty trolley being pushed down. The source is a Worldpanel by Numerator survey conducted in February 2026, with 11,638 respondents.
Nishita Pattni, a senior consultant at Worldpanel by Numerator, told the BBC that weight-loss jabs weren't "simply reducing spending" but "reshaping it".
"This isn't simply a story of shrinking demand. It's also a story of shifting demand."

Cornell's research found that users reduced spending most notably on calorie-dense, processed foods, with a 10% decrease in savoury snack purchases. They also bought less cheese, butter, soft drinks, and eggs, while increasing yoghurt purchases.

Advertisement

However, the study noted that households tend to revert to their pre-medication grocery spending patterns after discontinuing the drugs, sometimes shifting toward slightly less healthy food choices.

Impact on Eating Out and Mindful Eating

Weight-loss jabs also appear to influence dining habits outside the home. Nearly two-thirds of those surveyed by Worldpanel reported cutting out or attempting to reduce meals eaten out since starting their medication.

A graphic with four donut charts showing how GLP-1 users are eating out less often. The top two donut charts show 62% of users who report cutting out or trying to reduce meals out, and 40% wanting smaller portion sizes on menus. The bottom two charts show 25% wanting GLP-1 friendly menu sections, and 13% claiming to have cut out takeaways completely.

According to Worldpanel, over half of weight-loss jab users describe their eating approach as "mindful," guided by hunger cues rather than habit or routine.

Cornell's research further identified an 8% decline in spending at fast-food chains and coffee shops among users.

Cost Concerns and Demographic Trends

Despite potential savings in grocery and dining expenses, the cost of weight-loss medications remains a concern. Most UK patients pay privately for these drugs, with prescriptions often exceeding £300 per month.

A survey of 167 users conducted by Zava, an online doctor and pharmacy service selling weight-loss drugs, found that the primary reason for discontinuing medication was cost.

Two horizontal bar charts showing the results of a survey of GLP-1 users in March 2025. The top bar chart shows green bars of reported monthly savings among 323 respondents: 100 reported saving up to £50 on monthly food and drink costs, 99 reported saving £51 to £100, 42 reported saving £101 to £200, and 15 reported saving more than £200. The remaining 67 reported no savings. 61 don't know responses are excluded from the chart. The bottom bar chart shows pink bars of the most common reasons for pausing treatment among 167 respondents: 85 cited cost concerns, 38 cited side effects, 32 personal preference, 31 achieved goal weight, 18 plateaued weight loss and 7 doctor recommendation. People could select multiple answers.

Additionally, the Health Foundation, a charitable organization, reported that more affluent areas in the UK have higher average prescription rates despite lower obesity prevalence, based on data from a private provider.

User Experiences

Two case studies highlight personal experiences with weight-loss jabs.

Two case studies of weight-loss jab users - Brad Channer (aged 42 from Newcastle) and Annie Haslam (aged 71 from Redruth, Cornwall). We see pictures of both next to comments about their experiences of GLP-1 jabs. Annie Haslam, 71 from Redruth, Cornwall

Annie Haslam, 71, from Redruth, Cornwall, shared her journey: "I have taken weight-loss jabs for about 18 months and gone from 86kg to around 63.5kg. I buy less food, and less instantly satisfying food like biscuits or puddings. I eat a lot healthier and smaller portions. But I have spent a considerable amount on clothes as my old clothes just don't fit me anymore! I've gone from a size 18 to a size 10 or 12."

Brad Channer, 42, from Newcastle, said: "I've been taking Mounjaro for almost two years. I've gone from about 106kg down to 80kg but I had to stop for a little while because of the cost. Before taking the jabs I didn't have the willpower to walk past a Greggs and not have a sausage roll or a pub and have a pint. These days we buy more protein-based foods and I spend more on clothing because I am more confident about my appearance."

This article was sourced from bbc

Advertisement

Related News